Market Overview:
The global Valacyclovir HCl market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of herpes simplex virus (HSV) infections, rising demand for Valacyclovir HCl in emerging markets, and growing awareness about the benefits of Valacyclovir HCl. Based on type, the global Valacyclovir HCl market is segmented into ≥98% purity and ＜ 98% purity segments. The ≥98% purity segment is expected to account for a larger share of the global market in 2018 owing to its superior quality and efficacy as compared to other types of Valacyclovir HCl products available in the market. Based on application, the global Valacyclovir HCl market is segmented into valaciclovir tablet and valaciclovir capsule segments. The valaciclovir tablet segment is expected to account for a larger share of the global market in 2018 owing to its high demand among consumers across all regions.
Product Definition:
A prodrug of acyclovir, Valacyclovir HCl is an antiviral medication used to treat herpes zoster (shingles), genital herpes, and cold sores. It is also used to prevent cytomegalovirus (CMV) infections in people with HIV/AIDS.
≥98% Purity:
Valacyclovir is a prescription drug used to treat the symptoms of the common cold, including upper respiratory tract infections. It works by blocking viral replication and reducing inflammation at the cellular level. The drug has been studied for its use in treating patients with HIV-1 infection; however, it has not been approved by the U.
＜ 98% Purity:
98% Purity is a form of Valacyclovir hydrochloride. It's an antiviral medication used to treat the common cold, flu, and other viral infections. According to the Centers for Disease Control and Prevention (CDC), around 50 million people get infected with influenza each year in U.S., which leads to over 9 million hospitalizations and about 26,000 deaths annually.
Application Insights:
Valacyclovir tablet was the largest application segment and accounted for a revenue share of more than 60% in 2017. The product is used to treat various viral infections, including herpes simplex virus (HSV), cytomegalovirus (CMV), adenovirus, and varicella zoster virus. It is also used as an antiviral agent in the treatment of hepatitis infection. Furthermore, it has been found effective against a number of other diseases such as stromal cell lymphoma, keratinization disorders like eczema and psoriasis, chickenpox disease complications like encephalitis & pneumonia among others.
The market for valacyclovir capsules is expected to witness significant growth over the forecast period owing to its ability to act as both an anti-viral agent.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturers and suppliers coupled with high awareness levels among individuals about their health is expected to drive the regional demand for valacyclovir hydrochloride. Moreover, increasing cases of shingles are also anticipated to boost product demand over the forecast period.
Asia Pacific is expected to witness significant growth over the coming years owing to an increase in healthcare expenditure and rising penetration of generic drugs due to patent expirations or regulatory changes.
The key players operating in this region are either local companies or multinational giants like GlaxoSmithKline plc.
Growth Factors:
- Increasing incidence of herpes simplex virus (HSV) infections: The global incidence of HSV infections is increasing, due to various factors such as changing demographics, increased travel and sexual promiscuity. This is expected to drive the demand for Valacyclovir HCl in the coming years.
- Growing awareness about Valacyclovir HCl: There is a growing awareness among people about the benefits of using Valacyclovir HCl for treating HSV infections. This is likely to boost the demand for this drug in the near future.
- Rising prevalence of HIV/AIDS: The global prevalence of HIV/AIDS is on the rise, which has led to an increase in cases of opportunistic viral infections such as HSV-2 infection. This is expected to create a strong demand for Valacyclovir HCl in the coming years.
- Technological advancements: The development and commercialization of new technologies are helping improve diagnosis and treatment options for HSV-2 infection, which will spur growth in the market for Valacyclovir HCl over time .
Scope Of The Report
Report Attributes
Report Details
Report Title
Valacyclovir HCl Market Research Report
By Type
≥98% Purity, ＜ 98% Purity
By Application
Valacyclovir Tablet, Valacyclovir Capsule
By Companies
Sun Pharmaceutical, Divis, Yung Zip Chemical, Yichang Tianren Pharmaceutical, Changzhou Kony Pharmaceutical, TIEN (Tianjin) Pharmaceutical, Anqing World Chemical, Fuan Pharmaceutical, Hubei Chenfang Pharmaceutical Chemical, Hubei Teyer Pharmaceutical, Sun Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Valacyclovir HCl Market Report Segments:
The global Valacyclovir HCl market is segmented on the basis of:
Types
≥98% Purity, ＜ 98% Purity
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Valacyclovir Tablet, Valacyclovir Capsule
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sun Pharmaceutical
- Divis
- Yung Zip Chemical
- Yichang Tianren Pharmaceutical
- Changzhou Kony Pharmaceutical
- TIEN (Tianjin) Pharmaceutical
- Anqing World Chemical
- Fuan Pharmaceutical
- Hubei Chenfang Pharmaceutical Chemical
- Hubei Teyer Pharmaceutical
- Sun Pharmaceutical
Highlights of The Valacyclovir HCl Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ≥98% Purity
- ＜ 98% Purity
- By Application:
- Valacyclovir Tablet
- Valacyclovir Capsule
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Valacyclovir HCl Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Valacyclovir is an antiviral medication used to treat herpes simplex virus (HSV) infections. It is also used to prevent HSV infections in people who are at high risk for them, such as those with HIV/AIDS or cancer. Valacyclovir works by stopping the spread of the virus from one person to another.
Some of the major companies in the valacyclovir hcl market are Sun Pharmaceutical, Divis, Yung Zip Chemical, Yichang Tianren Pharmaceutical, Changzhou Kony Pharmaceutical, TIEN (Tianjin) Pharmaceutical, Anqing World Chemical, Fuan Pharmaceutical, Hubei Chenfang Pharmaceutical Chemical, Hubei Teyer Pharmaceutical, Sun Pharmaceutical.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Valacyclovir HCl Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Valacyclovir HCl Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Valacyclovir HCl Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Valacyclovir HCl Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Valacyclovir HCl Market Size & Forecast, 2020-2028
4.5.1 Valacyclovir HCl Market Size and Y-o-Y Growth
4.5.2 Valacyclovir HCl Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 ≥98% Purity
5.2.2 ＜ 98% Purity
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Valacyclovir Tablet
6.2.2 Valacyclovir Capsule
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Valacyclovir HCl Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Valacyclovir HCl Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 ≥98% Purity
9.6.2 ＜ 98% Purity
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Valacyclovir Tablet
9.10.2 Valacyclovir Capsule
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 ≥98% Purity
10.6.2 ＜ 98% Purity
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Valacyclovir Tablet
10.10.2 Valacyclovir Capsule
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 ≥98% Purity
11.6.2 ＜ 98% Purity
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Valacyclovir Tablet
11.10.2 Valacyclovir Capsule
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 ≥98% Purity
12.6.2 ＜ 98% Purity
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Valacyclovir Tablet
12.10.2 Valacyclovir Capsule
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 ≥98% Purity
13.6.2 ＜ 98% Purity
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Valacyclovir Tablet
13.10.2 Valacyclovir Capsule
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Valacyclovir HCl Market: Competitive Dashboard
14.2 Global Valacyclovir HCl Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sun Pharmaceutical
14.3.2 Divis
14.3.3 Yung Zip Chemical
14.3.4 Yichang Tianren Pharmaceutical
14.3.5 Changzhou Kony Pharmaceutical
14.3.6 TIEN (Tianjin) Pharmaceutical
14.3.7 Anqing World Chemical
14.3.8 Fuan Pharmaceutical
14.3.9 Hubei Chenfang Pharmaceutical Chemical
14.3.10 Hubei Teyer Pharmaceutical
14.3.11 Sun Pharmaceutical
